131 results
Page 4 of 7
8-K
EX-99.1
1fh4bukzs t53t
3 Jun 19
Other Events
4:02pm
8-K
EX-99.1
dkyfp98s le9tx
15 May 19
Achieved its Primary Endpoint in Previously Treated IDH1 Mutant Cholangiocarcinoma
4:13pm
8-K
EX-99.1
1w06yv1y
2 May 19
Other Events
3:24pm
8-K
EX-3.1
gq3hgx00i4nv po3s
19 Dec 18
Amendments to Articles of Incorporation or Bylaws
4:30pm
8-K
EX-99.1
hiuzj7x rr
3 Dec 18
Other Events
4:03pm
8-K
EX-99.2
d0c1c7cw1o pwc29m215
3 Dec 18
Other Events
4:03pm
8-K
EX-99.1
9ajklzryh innek2ysa
16 Nov 18
Agios Presents Updated Data from Phase 1 Dose-Escalation Study ofAG-881 in Patients with IDH Mutant Positive Advanced Glioma
4:01pm
8-K
EX-99.1
bnu4dj61lw96y 4csppi
20 Jul 18
FDA Grants Approval of TIBSOVO®, the First Oral, Targeted Therapy for Adult Patients
11:21am
8-K
EX-99.2
f5d3j u1l9
4 May 18
Results of Operations and Financial Condition
7:07am